Stuyvesant Capital Management’s Pfizer PFE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2018
Q4 | $3.26M | Sell |
78,755
-63,245
| -45% | -$2.62M | 7.93% | 1 |
|
|
2018
Q3 | $5.94M | Sell |
142,000
-2,266
| -2% | -$94.7K | 11.39% | 1 |
|
|
2018
Q2 | $4.97M | Sell |
144,266
-438
| -0.3% | -$15.1K | 9.25% | 1 |
|
|
2018
Q1 | $4.87M | Sell |
144,704
-1,027
| -0.7% | -$34.6K | 9.93% | 1 |
|
|
2017
Q4 | $5.01M | Sell |
145,731
-1,318
| -0.9% | -$45.3K | 9.06% | 2 |
|
|
2017
Q3 | $4.98M | Buy |
147,049
+42,845
| +41% | +$1.45M | 10.13% | 1 |
|
|
2017
Q2 | $3.32M | Buy |
104,204
+3,268
| +3% | +$104K | 6.55% | 2 |
|
|
2017
Q1 | $3.28M | Buy |
100,936
+5,533
| +6% | +$180K | 6.91% | 3 |
|
|
2016
Q4 | $2.94M | Buy |
95,403
+14,203
| +17% | +$438K | 6.33% | 4 |
|
|
2016
Q3 | $2.61M | Hold |
81,200
| – | – | 6.06% | 5 |
|
|
2016
Q2 | $2.71M | Buy |
81,200
+527
| +0.7% | +$17.6K | 5.36% | 6 |
|
|
2016
Q1 | $2.27M | Sell |
80,673
-2,398
| -3% | -$67.4K | 5% | 9 |
|
|
2015
Q4 | $2.54M | Hold |
83,071
| – | – | 6.4% | 6 |
|
|
2015
Q3 | $2.48M | Sell |
83,071
-7,905
| -9% | -$236K | 6.25% | 6 |
|
|
2015
Q2 | $2.89M | Buy |
90,976
+1,871
| +2% | +$59.5K | 6.31% | 4 |
|
|
2015
Q1 | $2.94M | Buy |
+89,105
| New | +$2.94M | 6.7% | 2 |
|